Rapid and large-scale implementation of HCV treatment advances in France, 2007 –2015

The last decade was marked by major advances in HCV treatment with the introduction of first wave protease inhibitors (1st-wave PIs, telaprevir or boceprevir) in 2011 and second direct-acting antivirals (2nd-w...

Source: BMC Infectious Diseases - December 20, 2017 Category: Infectious Diseases Authors: C écile Brouard, Marjorie Boussac-Zarebska, Christine Silvain, Julien Durand, Victor de Lédinghen, Josiane Pillonel and Elisabeth Delarocque-Astagneau Tags: Research article Source Type: research